Ledger.Open graph →
SEC Form D · Amendment · filed May 17, 2024

Hopewell Therapeutics, Inc

Offering
$10.0M
Sold
$7.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Woburn, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Jonathan Reis · Wellesley, MADirectorJake Xia · Woburn, MADirectorSara Loewel · BROOKLYN, NYDirectorQiaobing V. Xu · Woburn, MAExec · DirectorC. E. Springman · Bellevue, WAExec · DirectorLiat Bycel · San Francisco, CADirectorXutian V. Jing · Woburn, MADirectorNan V. Shen · Woburn, MADirectorThomas Hennessey · Woburn, MADirectorBrian L. Burns · PHOENIX, AZDirectorKjiel Carlson · El Segundo, CAExec · DirectorJesse Clurman · BROOKLYN, NYDirectorNan V. Shen · Woburn, MADirectorDavid Karandish · St. Louis, MODirectorJames L. Goulka · PHOENIX, AZDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗